report cover1

Global Acute Viral Rhinosinusitis Treatment Market " (By Treatment: Saline Nasal Spray, Nasal Corticosteroids, Decongestants, NSAIDs, and Others; By Route of Administration: Topical, Nasal, Oral, and Injectable; By Distribution Channel: Online Pharmacies, Retail Pharmacies, and Hospital Pharmacies; and By Infection Type: Rhinovirus [Picornavirus] and Non-Rhinovirus)”- Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2023-2030

A prominent research firm, Cognizance Market Research added a cutting-edge industry report on the “Global Acute Viral Rhinosinusitis Treatment Market”. The report studies the current as well as past growth trends and opportunities for the market to gain valuable insights during the forecast period from 2023 to 2030.

Global Acute Viral Rhinosinusitis Treatment Market Analysis:

According to cognizance market research, the global acute viral rhinosinusitis treatment market was valued at US$ 1,967.3 Million in 2022 and is anticipated to reach US$ 3,879.0 Million by the end of 2030 with a CAGR of 8.9% from 2023 to 2030.

acute viral rhinosinusitis treatment market

What is Global Acute Viral Rhinosinusitis Treatment Market?

Rhinosinusitis is a common medical condition that many patients seek treatment for. There are different types of rhinosinusitis such as acute, subacute, recurrent acute and chronic rhinosinusitis. Acute rhinosinusitis can be caused by bacteria or virus. However, most cases of acute rhinosinusitis are caused by viral infections that accompany the common cold. For patients with mild symptoms such as mild pain and temperature less than 101°F (38.3°C), symptomatic treatment with analgesics, decongestants, and saline nasal irrigation is appropriate.

Acute rhinosinusitis (ARS) typically lasts less than four weeks and is usually caused by a viral infection associated with the common cold. The different types of rhinosinusitis are classified based on the duration of symptoms. These include acute rhinosinusitis, sub-acute rhinosinusitis, chronic rhinosinusitis, and recurrent acute rhinosinusitis.

The market offers a variety of treatment options, including over-the-counter drugs such as nasal decongestants, antihistamines, and pain relievers, as well as prescription drugs such as antibiotics and steroids. There are also various therapeutic approaches available, such as home remedies, steam inhalation, and other natural remedies. The market for acute viral rhinosinusitis treatment is expected to grow significantly in the coming years due to the increasing prevalence of acute viral rhinosinusitis and growing awareness about various treatment options.

Global Acute Viral Rhinosinusitis Treatment Market Outlook:

Antibiotics have been shown to often be ineffective in treating the symptoms of bacterial acute rhinosinusitis (ABRS). Therefore, it is now widely understood that it is important to evaluate each patient’s condition before prescribing antibiotics, considering the negative consequences, such as drug resistance that can result from their overuse.

In contrast, intranasal corticosteroids (ARS) have been shown to be helpful in treating post-viral acute rhinosinusitis. To meet the demand for these treatments, manufacturers are increasing their production of saline nasal irrigation and over-the-counter analgesics.

Amoxicillin and clavulanate are recommended for people at risk of developing pneumococcal resistance. This combination therapy is becoming more widely available from companies in the Global Acute Viral Rhinosinusitis Treatment Market as the initial treatment of choice for ABRS patients without risk factors for resistance.

Children are more commonly prescribed amoxicillin and clavulanate than adults. However, there is now an increasing emergence of antimicrobial resistance among respiratory pathogens, leading to the need for more research and development efforts in routine conjugated pneumococcal vaccination for children.

A higher dose of amoxicillin and clavulanate is recommended for patients at high risk of pneumococcal resistance. Due to the increasing microbial resistance to antibiotics, amoxicillin or amoxicillin-clavulanate are becoming more popular choices for treating ABRS.

Nasal saline irrigation has been found to effectively remove or reduce debris and pathogens from the nares, resulting in symptomatic relief. Companies in the Global Acute Viral Rhinosinusitis Treatment Market are increasing their production of topical intranasal therapies to reduce congestion in patients. Topical corticosteroid nasal sprays can help reduce mucosal inflammation, reducing stenosis of the sinus drainage pathways. Therefore, nasal corticosteroids are expected to be the second-highest revenue earner among all treatment types in the Global Acute Viral Rhinosinusitis Treatment Market.

Segment Analysis:

Here’s the corrected paragraph with some adjustments for clarity and consistency:

Based on treatment options, the global market for acute viral rhinosinusitis treatment is categorized into nasal sprays, nasal corticosteroids, decongestants, NSAIDs, and other therapies.

In terms of the route of administration, the global market for acute viral rhinosinusitis treatment is classified into topical, nasal, oral, and injectable methods.

As for distribution channels, the global market for the treatment of acute viral rhinosinusitis is divided into online pharmacies, retail pharmacies, and hospital pharmacies.

Based on the type of infection, the global market for acute viral rhinosinusitis treatment is further segmented into rhinovirus (picornavirus) and non-rhinovirus infections.

Geographical Analysis:

North America currently holds a dominant position in the global market for acute viral rhinosinusitis treatments, and this trend is expected to continue throughout the forecast period. Acute viral rhinosinusitis is characterized by the rapid worsening or onset of symptoms in patients with chronic sinusitis, often accompanied by purulent drainage from the sinuses, as observed during nasal endoscopy.

In the Asia Pacific region, increased healthcare spending and greater awareness of sinusitis are anticipated to drive market expansion. Additionally, a rise in investment in pharmaceutical drug research and development is projected to further fuel market growth in this region.

Europe is also expected to experience market growth due to the increased demand for medications to treat acute viral rhinosinusitis. Factors such as a focus on discovering novel treatment medications and heightened awareness of acute viral rhinosinusitis are likely to be driving forces in this region’s market expansion.geographical analysis

The report offers the revenue of the global acute viral rhinosinusitis treatment market for the period 2020-2030, considering 2020 and 2021 as historical years, 2022 as the base year, and 2023 to 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global acute viral rhinosinusitis treatment market for the forecast period. The global acute viral rhinosinusitis treatment market report provides insights and in-depth analysis into developments impacting enterprises and businesses on a regional and global level. The report covers the global acute viral rhinosinusitis treatment market performance in terms of revenue contribution from several segments and comprises a detailed analysis of key drivers, trends, restraints, and opportunities prompting revenue growth of the global acute viral rhinosinusitis treatment market.

The report has been prepared after wide-ranging secondary and primary research. Secondary research included internet sources, numerical data from government organizations, trade associations, and websites. Analysts have also employed an amalgamation of bottom-up and top-down approaches to study numerous phenomena in the Global Acute Viral Rhinosinusitis Treatment Market. Secondary research involved a detailed analysis of significant players’ product portfolios. Literature reviews, press releases, annual reports, white papers, and relevant documents have been also studied to understand the global acute viral rhinosinusitis treatment market. Primary research involved a great extent of research efforts, wherein experts carried out interviews telephonic as well as questioner-based with industry experts and opinion-makers.

The report includes an executive summary, along with a growth pattern of different segments included in the scope of the study. The Y-o-Y analysis with elaborate market insights has been provided in the report to comprehend the Y-o-Y trends in the Global acute viral rhinosinusitis treatment market. Additionally, the report focuses on altering competitive dynamics in the global market. These indices serve as valued tools for present market players as well as for companies interested in participating in the Global Acute Viral Rhinosinusitis Treatment Market. The subsequent section of the Global Acute Viral Rhinosinusitis Treatment Market report highlights the USPs, which include key industry events (product launch, research partnership, acquisition, etc.), technology advancements, pipeline analysis, prevalence data, and regulatory scenario.

Global Acute Viral Rhinosinusitis Treatment Market Competitive Landscape:

There are several small and major firms participating in the highly fragmented global acute viral rhinosinusitis treatment market. The new strategies formed by companies revolve around accuracy and precision. The new technology used by brands is helping them launch new types of products like seizure sleep monitors and smartwatch seizure detection devices. The following are some of the major market participants:

  • Amneal Pharmaceuticals LLC
  • AstraZeneca plc
  • Bayer AG
  • Bristol-Myers Squibb
  • Reddy’s Laboratories Inc.
  • Eli Lilly and Company
  • Fresenius Kabi USA LLC
  • GlaxoSmithKline plc
  • Hikma Pharmaceuticals plc
  • Janssen Pharmaceuticals Inc.
  • Merck & Co. Inc.
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Wockhardt

The report explores the competitive scenario of the Global Acute Viral Rhinosinusitis Treatment Market. Major players working in the Global Acute Viral Rhinosinusitis Treatment Market have been named and profiled for unique commercial attributes. Company overview (company description, product portfolio, geographic presence, employee strength, Key management, etc.), financials, SWOT analysis, recent developments, and key strategies are some of the features of companies profiled in the Global Acute Viral Rhinosinusitis Treatment Market report.


Global Acute Viral Rhinosinusitis Treatment Market, By Treatment:

  • Saline Nasal Spray
  • Nasal Corticosteroids
    • Fluticasone
    • Budesonide
    • Mometasone
    • Others
  • Decongestants
    • Topical Decongestants
    • Systemic Decongestants
  • NSAIDs
    • Acetaminophen
    • Ibuprofen
    • Aspirin
    • Others
  • Others

Global Acute Viral Rhinosinusitis Treatment Market, By Route of Administration:

  • Topical
  • Nasal
  • Oral
  • Injectable

Global Acute Viral Rhinosinusitis Treatment Market, By Distribution Channel:

  • Online Pharmacies
  • Retail Pharmacies
  • Hospital Pharmacies

Global Acute Viral Rhinosinusitis Treatment Market, By Infection Type:

  • Rhinovirus (Picornavirus)
  • Non-Rhinovirus
    • Influenza
    • Enterovirus
    • Adenovirus
    • Others

Global Acute Viral Rhinosinusitis Treatment Market, By region:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia & New Zealand
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of the Middle East and Africa
Complete the form below and we'll get back to you shortly
Table of Content

Research Methodology: Aspects

Market research is a crucial tool for organizations aiming to navigate the dynamic landscape of customer preferences, business trends, and competitive landscapes. At Cognizance Market Research, acknowledging the importance of robust research methodologies is vital to delivering actionable insights to our clientele. The significance of such methodologies lies in their capability to offer clarity in complexity, guiding strategic management with realistic evidence rather than speculation. Our clientele seek insights that excel superficial observations, reaching deep into the details of consumer behaviours, market dynamics, and evolving opportunities. These insights serve as the basis upon which businesses craft tailored approaches, optimize product offerings, and gain a competitive edge in an ever-growing marketplace.

The frequency of information updates is a cornerstone of our commitment to providing timely, relevant, and accurate insights. Cognizance Market Research adheres to a rigorous schedule of data collection, analysis, and distribution to ensure that our reports reflect the most current market realities. This proactive approach enables our clients to stay ahead of the curve, capitalize on emerging trends, and mitigate risks associated with outdated information.

Our research process is characterized by meticulous attention to detail and methodological rigor. It begins with a comprehensive understanding of client objectives, industry dynamics, and research scope. Leveraging a combination of primary and secondary research methodologies, we gather data from diverse sources including surveys, interviews, industry reports, and proprietary databases. Rigorous data analysis techniques are then employed to derive meaningful insights, identify patterns, and uncover actionable recommendations. Throughout the process, we remain vigilant in upholding the highest standards of data integrity, ensuring that our findings are robust, reliable, and actionable.

Key phases involved in in our research process are mentioned below:


Understanding Clients’ Objectives:

Extensive Discussions and Consultations:

  • We initiate in-depth discussions and consultations with our clients to gain a comprehensive understanding of their objectives. This involves actively listening to their needs, concerns, and aspirations regarding the research project.
  • Through these interactions, we aim to uncover the underlying motivations driving their research requirements and the specific outcomes they hope to achieve.

Industry and Market Segment Analysis:

  • We invest time and effort in comprehensively understanding our clients’ industry and market segment. This involves conducting thorough research into market trends, competitive dynamics, regulatory frameworks, and emerging opportunities or threats.
  • By acquiring a deep understanding of the broader industry landscape, we can provide context-rich insights that resonate with our clients’ strategic objectives.

Target Audience Understanding:

  • We analyze our clients’ target audience demographics, behaviors, preferences, and needs to align our research efforts with their consumer-centric objectives. This entails segmenting the audience based on various criteria such as age, gender, income level, geographic location, and psychographic factors.
  • By understanding the nuances of the target audience, we can tailor our research methodologies to gather relevant data that illuminates consumer perceptions, attitudes, and purchase intent.


Identifying Challenges and Opportunities:

  • We proactively identify the challenges and opportunities facing our clients within their respective industries. This involves conducting SWOT (Strengths, Weaknesses, Opportunities, Threats) analyses and competitive benchmarking exercises.
  • By identifying potential obstacles and growth drivers, we can provide strategic recommendations that help our clients navigate complexities and capitalize on emerging opportunities effectively.

Grasping Specific Goals:

  • We delve into the intricacies of our clients’ objectives to gain clarity on the specific goals they aim to accomplish through the research. This entails understanding their desired outcomes, such as market expansion, product development, or competitive analysis.
  • By gaining a nuanced understanding of our clients’ goals, we can tailor our research approach to address their unique challenges and opportunities effectively.

Data Collection:


Primary Research Process:

  • Surveys: We design and administer surveys tailored to capture specific information relevant to our clients’ objectives. This may involve employing various survey methodologies, such as online, telephone, or face-to-face interviews, to reach target audiences effectively.
  • Interviews: We conduct structured or semi-structured interviews with key stakeholders, industry experts, or target consumers to gather in-depth insights and perspectives on relevant topics. These interviews allow us to probe deeper into specific issues and uncover valuable qualitative data.
  • Focus Groups: We organize focus group discussions with carefully selected participants to facilitate interactive discussions and gather collective opinions, attitudes, and preferences. This qualitative research method provides rich contextual insights into consumer behaviors and perceptions.
  • Observations: We conduct observational research by directly observing consumer behaviors, interactions, and experiences in real-world settings. This method enables us to gather objective data on consumer actions and reactions without relying on self-reported information.

Secondary Research Process:

  • Literature Review: We conduct comprehensive literature reviews to identify existing studies, academic articles, and industry reports relevant to the research topic. This helps us gain insights into previous research findings, theoretical frameworks, and best practices.
  • Industry Reports: We analyze industry reports published by reputable trade associations (whitepapers, research studies, etc.), and government agencies (U.S. Census Bureau, Bureau of Labor Statistics, and Securities and Exchange Commission etc.) to obtain macro-level insights into market trends, competitive landscapes, and industry dynamics.
  • Government Publications: We review government publications, such as economic reports, regulatory documents, and statistical databases, to gather relevant data on demographics, market size, consumer spending patterns, and regulatory frameworks.
  • Online Databases: We leverage online databases, such as industry portals, and academic repositories (PubMed Central (PMC), ScienceDirect, SSRN (Social Science Research Network), Directory of Open Access Journals (DOAJ), NCBI, etc.), to access a wide range of secondary data sources, including market statistics, financial data, and industry analyses.





Data Analysis:

The data analysis phase serves as a critical juncture where raw data is transformed into actionable insights that inform strategic decision-making. Through the utilization of analytical methods such as statistical analysis and qualitative techniques like thematic coding, we uncover patterns, correlations, and trends within the data. By ensuring the integrity and validity of our findings, we strive to provide clients with accurate and reliable insights that accurately reflect the realities of the market landscape.



Transformation of Raw Data:

  • Upon collecting the necessary data, we transition into the data analysis phase, where raw data is processed and transformed into actionable insights. This involves organizing, cleaning, and structuring the data to prepare it for analysis.

Utilization of Analytical Methods:

  • Depending on the research objectives, we employ a diverse range of analytical methods to extract meaningful insights from the data. These methods include statistical analysis, trend analysis, regression analysis, and qualitative coding.

Statistical Analysis:

  • Statistical tools are instrumental in uncovering patterns, correlations, and trends within the data. By applying statistical techniques such as descriptive statistics, hypothesis testing, and multivariate analysis, we can discern relationships and derive valuable insights.

Qualitative Analysis Techniques:

  • In addition to quantitative analysis, we leverage qualitative analysis techniques to gain deeper insights from qualitative data sources such as interviews or open-ended survey responses. One such technique is thematic coding, which involves systematically categorizing and interpreting themes or patterns within qualitative data.

Integrity and Validity Maintenance:

  • Throughout the analysis process, we maintain a steadfast commitment to upholding the integrity and validity of our findings. This entails rigorous adherence to established methodologies, transparency in data handling, and thorough validation of analytical outcomes.

Data Validation:

The final phase of our research methodology is data validation, which is essential for ensuring the reliability and credibility of our findings. Validation involves scrutinizing the collected data to identify any inconsistencies, errors, or biases that may have crept in during the research process. We employ various validation techniques, including cross-referencing data from multiple sources, conducting validity checks on survey instruments, and seeking feedback from independent experts or peer reviewers. Additionally, we leverage internal quality assurance protocols to verify the accuracy and integrity of our analysis. By subjecting our findings to rigorous validation procedures, we instill confidence in our clients that the insights they receive are robust, reliable, and trustworthy.


Importance of Data Validation:

  • Data validation is the final phase of the research methodology, crucial for ensuring the reliability and credibility of the findings. It involves a systematic process of reviewing and verifying the collected data to detect any inconsistencies, errors, or biases.

Scrutiny of Collected Data:

  • The validation process begins with a thorough scrutiny of the collected data to identify any discrepancies or anomalies. This entails comparing data points, checking for outliers, and verifying the accuracy of data entries against the original sources.

Validation Techniques:

  • Various validation techniques are employed to ensure the accuracy and integrity of the data. These include cross-referencing data from multiple sources to corroborate findings, conducting validity checks on survey instruments to assess the reliability of responses, and seeking feedback from independent experts or peer reviewers to validate the interpretation of results.

Internal Quality Assurance Protocols:

  • In addition to external validation measures, internal quality assurance protocols are implemented to further validate the accuracy of the analysis. This may involve conducting internal audits, peer reviews, or data validation checks to ensure that the research process adheres to established standards and guidelines.

Report Scope:



Market Size

US$ 3,879.0 Million (2030)

Compound Annual Growth Rate (CAGR)


Base Year


Forecast Period


Forecast Units

Value (US$ Million)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Geographies Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Countries Covered

U.S., Canada, Germany, U.K., France, Spain, Italy, Rest of Europe, Japan, China, India, Australia & New Zealand, South Korea, Rest of Asia Pacific, Brazil, Mexico, Rest of Latin America, GCC, South Africa, Rest of Middle East & Africa

Key Companies Profiled

Amneal Pharmaceuticals LLC, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb, Dr. Reddy’s Laboratories Inc., Eli Lilly and Company, Fresenius Kabi USA LLC, GlaxoSmithKline plc, Hikma Pharmaceuticals plc, Janssen Pharmaceuticals Inc., Merck & Co. Inc., Mylan N.V., Novartis AG, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Inc

Key Questions Answered in Acute Viral Rhinosinusitis Treatment Market Report

It was Valued at US$ 1,967.3  million in 2022.

It is projected to reach more than US$ 3,879.0  Million by 2030.

It is anticipated to be 8.9%from 2023 to 2030.

Trend: Increased Viral Infections, Advances in Diagnosis, Rising Antibiotic Stewardship, etc.

Driver: Growing Incidence, Awareness and Education, Research and Development etc.

Opportunities: Development of Antiviral Drugs, Consumer Preference for Natural Remedies, etc.

Challenges: Antibiotic Overuse, Regulatory Hurdles, etc

Amneal Pharmaceuticals LLC, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb, Dr. Reddy’s Laboratories Inc., Eli Lilly and Company, Fresenius Kabi USA LLC, GlaxoSmithKline plc, Hikma Pharmaceuticals plc, Janssen Pharmaceuticals Inc., Merck & Co. Inc., Mylan N.V., Novartis AG, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Inc

Single User - $4,600.00

It allows one person, the buyer, to have the sole rights and access to the purchased report. Further distribution of the product is strictly prohibited.

It allows the purchased product to be shared among 1-7 employees of your organization within the same geographical location.

It allows the purchased product to be shared among all employees of your organization irrespective of their geographical location.

Need a Custom Report?

We can customize every report – free of charge – including purchasing stand-alone sections or country-level reports

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Business Development

small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
Ask an Expert